Treatment Costs and Quality of Life with Granulocyte-Macrophage Colony-Stimulating Factor in Patients with Antineoplastic Therapy-Related Febrile Neutropenia

Carin Uyl - de Groot, E Vellenga, EGE de Vries, Bob Löwenberg, Gerrit Stoter, FFH Rutten

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)351-360
Number of pages10
JournalPharmacoeconomics (Print)
Issue number12
Publication statusPublished - 1997

Research programs

  • EMC 04-01-DD-08-01
  • EMC MM-02-41-04

Cite this